It is generally accepted that the biological activity of the pituitary adrenocorticotropic hormone (corticotropin, ACTH) is unstable under oxidizing conditions. For example, Dixon, Moore, StackDunne & Young (1951) have advocated the use of anti-oxidants to diminish oxidative inactivation during extraction and purification of the hormone, and the practice has often been adopted by later workers. No quantitative data on the subject are, however, available.
The first evidence that the oxidation process may be reversible, at least in part, was provided by Kuehl, Meisinger, Brink & Folkers (1953) . These workers showed that corticotropin B, a highly active preparation made by partial peptic hydrolysis of purified pituitary extracts, could be oxidized by the action of oxygen in the presence of ferric iron, to a product which was inactive in the ascorbic acid-depletion bioassay. The biological activity of the product could be restored by several days' contact with hydrogen sulphide. Attempts in several laboratories to repeat the reductive reactivation of oxidized hormone under the conditions advocated by Kuehl et al. (1953) have, however, been unsuccessful (Dixon & Stack-Dunne, 1955) .
The observations of Kuehl et al. (1953) are of interest from both the chemical and biological standpoints. First, it is generally agreed that the best corticotropin preparations now available contain no detectable sulphydryl groups, so that there is no obvious chemical explanation of the oxidation-reduction property. Secondly, the presence of an oxidation-reduction centre may also be of importance for the biological function of a * Part 1: Cortis-Jones, Crooke, Henly, Morris & Morris (1950) .
OXIDATION-REDUCTION OF CORTICOTROPIN
hormone which controls an oxidative process, the oxidation of cholesterol in the adrenal cortex to C19, and C21 precursors of the adrenal hormones.
The present work has been concerned with the determination of the optimum conditions for the oxidation and reduction of corticotropin. Some observations on the nature of the oxidationreduction centre in the hormone are reported. A preliminary account of part of this work has already been published (Dedman, Farmer & Morris, 1955) . EXPERIMENTAL
Bioassay methods
Adrenocorticotropic potency has been measured by the adrenal ascorbic acid-depletion method of Sayers, Sayers & Woodbury (1948) with minor modifications (Morris, 1951) . The particular corticotropin preparation used for chemical treatment was always bioassayed in the untreated state, together with the treated material, so that any change in biological potency brought about by the chemical treatment can be expressed as a percentage of the initial potency. The absolute potencies of many of the untreated preparations assayed against international standard corticotropin are also given.
The values given in Tables 2-4 are the best estimates of potency, the confidence limits of the estimate at P 0 95, calculated according to Pugsley (1946) , being given in parentheses.
Reagents
Analytical grade acetone was dried over anhydrous K2CO3 for 24 hr. and redistilled, the fraction of b.p. 56-57°b eing collected. Analytical grade acetic acid (2 1.) was mixed with water (50 ml.) and was boiled under reflux for 3 hr. The product was distilled through a 30 cm. x 2 cm. fractionating column packed with glass Fenske spirals and the fraction of b.p. 117-118°was collected. Ether (analytical grade) was freed from peroxides immediately before use by passage through a 20 cm. x 2-5 cm. column packed with A1203
(grade H, P. Spence and Co., Widnes).
Oxycellulose. This, with 10 % carboxyl content, was obtained from the Tennessee Eastman Co., Kingsport, Tenn., U.S.A. It was purified immediately before use by the method of Astwood, Raben, Payne & Grady (1951) by washing with N-HCI for 10 min., followed by water and finally with 0-I N-acetic acid for 10 min.
Resins. Cation-exchange resin Amberlite XE-97, 200-400 mesh (Chas. Lennig and Co., 18 York Buildings, London, W.C. 2), is a finely divided preparation of the carboxylic acid resin Amberlite IRC-50, and is also chemically identical with Amberlite XE-64. It was treated according to the method of Hirs, Moore & Stein (1953) to remove soluble and very fine material and was subsequently dried to constant weight over silica gel in vacuo. The anion-exchange resins Amberlite IR-4B and Amberlite IRA-400, 60-100 mesh (Chas. Lennig and Co.), were treated in sequence with 2N-HC1, water and 2N-Na2CO3 for three successive cycles, and were stirred for 30 min. with each reagent. The resins were finally converted into the acetate forms by treatment with 2N-acetic acid. Dowex 50 x 8, 200-400 mesh, and Dowex 50 x 16, 60-100 mesh, cation-exchange resins (Dow Chemical Co., Midland, Mich., U.S.A.) were treated with 4N-HCI and hot N-NaOH to remove soluble material according to the method of . Dowex 2 x 8, 60-100 mesh, anion-exchange resin (Dow Chemical Co.) was treated similarly to Amberlite IR-4B.
Preparation of crude corticotropin
The corticotropin preparations used were prepared from the anterior lobes of pig pituitary glands by minor modifications of published methods. Because of the wide variations in yields and potencies reported in the literature, a detailed description of the preparation is appended.
Whole pig pituitary glands, stored in anhydrous acetone, were received in the laboratory within five days of the death of the animal. The glands were stored for a further 24 hr. in fresh anhydrous acetone and the anterior lobes separated. These were thoroughly homogenized with anhydrous acetone in a high-speed blender and the homogenate was centrifuged. The precipitate was dried in vacuo. The dry powder assayed at 0-2-03 i.u./mg. Experience has shown that it is not possible to obtain high-potency preparations from a pituitary-gland powder assaying less than 0-2 i.u./mg.
The pituitary powder was extracted with acetic acid by the method of Payne, Raben & Astwood (1950) or the method of Dedman, Farmer, Morris & Morris (1952) . Both methods give products with potencies of 1-1-8 i.u./mg. It is particularly important that the acetic acid used should be freed from trace amounts of acetic anhydride as described under Reagents. The ether precipitate should be very thoroughly washed free from acetic acid with anhydrous acetone and dried in vacuo over silica gel.
Purification with oxycellulose. This step was carried out according to the procedure of Astwood et al. (1951) . The optimum amount of oxycellulose required per unit weight of crude corticotropin varies with different preparations of the latter and can only be found from trial experiments. The ratio appears to be quite reproducible for the same preparations of corticotropin and oxycellulose. The biological activities of oxycellulose concentrates prepared in this laboratory have been in the range 30-70 i.u./mg. but have seldom been less than 40 i.u./mg.
Ion-exchange chromatography. The method used was a modification of that of White & Fierce (1953) . The purified Amberlite XE-97 resin (20 g.) was mixed with N-NaOH (184 ml.) and M-NaCl (20-4 ml.), stirred for 1 hr. and allowed to stand for 48 hr. at room temperature. The pH of the supernatant was then 8-3. A column 30 cm. x 2 cm. was prepared by pouring the resin slurry into a suitable glass chromatographic tube in six equal portions. The column was then washed with 2-3 1. of 0-M-NaHCO3. The pH of the effluent liquid was then identical with that of the 0-1 MNaHCO3 wash liquid, . The upper 1-2 cm. of the resin was gently stirred and allowed to settle slowly in order to produce a flat upper surface.
An oxycellulose concentrate of corticotropin (100 mg.) was dissolved in water (10 ml.) and 0-2m-NaHCO3 (10 ml.) added dropwise with stirring. After a further 20 min.
stirring the mixture was centrifuged and the supernatant liquid transferred to the column. The flow rate was adjusted so that the solution entered the column during the course of about 2 hr. Chromatographic development wascontinued with O-lM-NaHCO3 at a flow rate of 15 ml./hr. Fractions (3 ml.) were collected by means of an automatic fraction collector, each fraction being taken into a tube containing 0-05 ml. of acetic acid, in order to reduce the period during Vol. 66 167 which the corticotropin was exposed to alkaline conditions. The ultraviolet absorption of each fraction was measured at 275 m,u in 1 cm. quartz cells with a Unicam SP. 500 spectrophotometer. Fig. 1 shows a typical separation obtained in this way. Three well-defined components have been found. These appear to correspond with the corticotropin fractions A1, A2 and A4 of Dixon & Stack-Dunne (1955) , obtained by chromatography on a similar ion-exchange resin at pH 6-7 and at a higher ionic strength. Accordingly their nomenclature has been adopted for these components.
Corticotropins A1 and A. were obtained from the NaHCO3 solutions by a combination of ion-exchange desalting and oxycellulose adsorption.
In a typical experiment, 135 ml. of 01IM-NaHCO, containing corticotropin A1 was adjusted to pH 3-5 with concentrated HCI and passed through a 9-8 cm. x 1-3 cm. column containing 7 g. of Dowex 50 x 16 cation-exchange resin in the H form. The column was washed with 20 ml. of 0-1 N-acetic acid and C1 ions were removed from the total effluent by passage through an 8-3 cm. x 1-3 cm. column containing 4 g. of Amberlite IR-4 B anion-exchange resin in the acetate form. The corticotropin in the chloride-free solution was adsorbed on to oxycellulose (150 mg.). Adsorption was complete after stirring for 20 hr. at room temperature. The oxycellulose was separated by centrifuging, washed with 0 1 N-acetic acid and the corticotropin eluted by shaking with 0-1N-HCI (3 ml.) for 1 hr. The oxycellulose was eluted with three further 1 ml. portions of 0.1 -HCI for 2 min. periods. The combined eluates were freed from HCI by passage through a 7-2 cm. x 0-7 cm. column of Dowex 2 x 8 anion-exchange resin (1-5 g.) Table 1 .
The work described in this paper has been carried out either with oxycellulose concentrates (OC) or with corticotropin A1. The existence of a reversible oxidation-reduction system has, however, been confirmed in corticotropin A2, and in corticotropin preparations which had been partially hydrolysed with HCI. The work of Kuehl et al. (1953) demonstrates the existence of a similar system in pepsinhydrolysed corticotropin. Quantitative estimation of the amino acids was carried out either by paper chromatography or by ion exchange. In the first method the amino acids were separated in a onedimensional chromatogram with the phenol-buffer, pH 12, or m-cresol-buffer, pH 8-4, system of McFarren (1951) . Standards (5, 10 and 15 ug.) of the particular amino acids to be estimated were chromatographed simultaneously on the same strip. After removal of the solvent the amino acid spots were developed with ninhydrin according to the method ofWael & Cadavieco (1954) . The coloured zones were cut out and the pigment was eluted with 50 % (v/v) aqueous propan-l-ol. After removal of the filter paper, the optical densities of the solutions were determined at 570 mi/ in a Unicam SP. 600 spectrophotometer. The amount of amino acid in the portion of hydrolysate was determined by comparison with standards which were chromatographed and developed simultaneously.
Complete amino acid analyses of a typical preparation of corticotropin A1, and of peroxide-oxidized material prepared from it, were carried out with the method of ionexchange chromatography on Dowex 50 x 8 resin , together with the improved photometric ninhydrin method of Moore & Stein (1954) . Unsatisfactory recoveries of arginine were obtained with the 15 cm. columns described by these authors for the separation of the basic amino acids. Substitution of Dowex 50 x 4 resin for this purpose gave satisfactory results. Well-defined zones were obtained for the acidic and neutral amino acids on the 100 cm. column of Dowex 50 x 8.
Preparation of peroxide-oxidized corticotropin A1
Corticotropin A1 (9-8 mg.) was dissolved in water (1-5 ml.) and 0-05N-sodium acetate solution (3-5 ml.) added. A 6% (w/v) H202 solution was added in three 0-05 ml. portions at 15 min. intervals. After a further 45 min. the reaction was stopped by the addition of 0-1 N-HCI (1-4 ml.). Excess of H202 was removed by shaking with about 20 mg. of platinum black, until a negative starch-potassium iodide reaction was obtained. The platinum was removed by centrifuging and 0-IM-NaCl solution (1 ml.) was added to the supernatant liquid. Sodium ions were removed from the solution by passage through a short column containing Dowex 50 x 16 cation-exchange resin (0-25 g.) in the hydrogen form, C1 ions were exchanged foracetate with Amberlite IR-4B anion-exchange resin in the acetate form (0-25 g.).
The oxidized corticotropin was adsorbed from the combined filtrate and washings on to acid-washed oxycellulose (50 mg.) during a period of 20 hr. Elution was carried out with 0-1N-HCI (3 x 2 ml.); CF ions were exchanged for acetate with Amberlite IR-4B acetate and the final eluate and washings freeze-dried. Yield, 7-0 mg.
Effect of pH on the oxidation of corticotropin A1 by hydrogen peroxide A volume (0-2 ml.) of a solution containing 1 mg.
of corticotropin Al/ml. was mixed with 0-6 ml. of the appropriate buffer (ionic strength I = 0-084) and 0-2 ml. of 0-2M-H202 added. After 30 min. at 250, 1 ml. of 2 N-acetic acid was added and the excess of H202 destroyed by the addition of a few milligrams of platinum black. After centrifuging to remove the platinum, the supernatant liquid was separated and a portion taken for bioassay. A volume (1 ml.) was treated with cysteine hydrochloride (20 mg.) and the mixture maintained at 780 for 18 hr. After cooling, the solution was diluted for bioassay (Table 2, Expt. 2). The buffers used were (a) acetic acid-sodium acetate, pH 5-0; (b) primary-secondary phosphate, pH 6-0, 7-0 and 8-0; (c) NaHCO3-Na2CO3, pH 8-5. Dixon, 1956 ). Corticotropin A1 (8-4 mg.) and histidine hydrochloride (4-64 mg.) were dissolved in water (2-1 ml.) and the pH of the mixture was brought to 9-2 by the addition of 0-2M-K2B407 solution (3-5 ml.). Potassium periodate (0 1M) in 0-2 N-KOH (0-625 ml.) was then added. After 8 min. KBH4 (16 mg.) was added with continuous stirring. Three minutes later acetic acid (0-2 ml.) was added dropwise. The mixture was stirred for 30 min., M-NaCl (0-7 ml.) was then added and Na+ ions were removed on a 5-1 cm. x 0-7 cm. column of Dowex 50 x 16 cation-exchange resin. Anions present in the effluent were exchanged for acetate by passage through a 10 cm. x 0-7 cm. column of Dowex 2 x 8 acetate. The combined effluent and washings were stirred for 20 hr. with oxycellulose (50 mg.) which had been previously washed with 0-1 N-acetic acid. The oxidized corticotropin was eluted from the oxycellulose with 0-1 N-HCI (2 ml.) followed by two washings (1 ml. each Ascorbic acid, ferrous sulphate and oxygen (cf. Udenfriend, Clark, Axelrod & Brodie, 1954) . Oxycellulose-purified corticotropin (1 mg.) was treated with 0-1 ml. of a solution containing ascorbic acid (25 mg.), FeSO4 (42 mg.) and ethylenediaminetetra-acetic acid (25 mg.) in water (3 ml.), and the pH adjusted to 5-5 with Na2HPO4 solution. The mixture was shaken in contact with air for 2 hr. and the reaction terminated by the addition of 0-1 N-acetic acid (1 ml.). All anions present in the solution were exchanged for acetate in Amberlite IRA-400 acetate. Portions of the eluate were taken for direct bioassay and for bioassay after reduction with cysteine hydrochloride (20 mg.) at 780 for 18 hr. (Table 2 , Expt. 6).
Photochemical oxidation (cf. Weil, Gordon & Buchert, 1951) . Corticotropin A1 (2 mg.) was dissolved in water (1.9 ml.) containing NaHCO3 (2-5 mg.) and methylene blue (0-1 mg.). The tube containing the mixture was cooled by a continuous flow of tap water. Irradiation was carried out with a bank of three 100w electric-light lamps, the centre lamp being placed 15 cm. from the sample tube. Samples (0-6 ml. each) were withdrawn at 10, 30 and 60 min. Hydrochloric acid (N, 0-035 ml.) and Dowex 50 x 16 (H form; 50 mg.) were added to each sample, which was shaken mechanically for 15 min. This procedure removed Na+ ions and methylene blue. The ion-exchange resin was removed by centrifuging, and a portion (0 05 ml.) of the supernatant liquid diluted for bioassay. The biological potencies of the products are given in Table 2 (Expt. 7).
A volume (0.5 ml.) of the remainder of each sample was evaporated to dryness in vacuo and hydrolysed by heating with 6N-HCI (0-2 ml.) in a sealed capillary at 1100 for 18 hr. The hydrolysates were freed from most of the HCI by repeated evaporation with water in vacuo. The samples, together with a hydrolysate of corticotropin Al prepared similarly, were subjected to paper electrophoresis in phosphate buffer (0 066M, pH 5.9) at a potential gradient of 2-4v/cm. for 17 hr. The positions of the histidine zones were determined on a reference strip by development with the diazotized p-anisidine reagent of Sanger & Tuppy (1951) . The corresponding areas for the hydrolysates were cut out and the histidine was eluted with 0-1N-HCI (2 ml.). The histidine contents were determined by the colorimetric procedure of MacPherson (1942) OXIDATION-REDUCTION OF CORTICOTROPIN added and the mixture maintained at 780 for 18 hr. The solution was then diluted for bioassay. (b) 0-2 ml. was mixed with 0-8 ml. of a solution of cysteine acetate prepared by anion exchange from a solution of cysteine hydrochloride (25 mg./ml.). The mixture was kept at 780 for 18 hr. and diluted for bioassay. (c) 0-2 ml. was mixed with thioglycollic acid (0-02 ml., 26-5 mg.), diluted to 1 ml. and the pH adjusted to 2 5. The mixture was heated at 780 for 18 hr. and diluted for bioassay (Table 3 , Expt. 8).
Other reducing agents at 37°. Oxycellulosepurified corticotropin (2.5 mg.) in 0 004N-acetic acid (2-5 ml.) was oxidized with H202 and the solution freed from excess of H202 as described above.
(a) 0-5 ml. was diluted to 1 ml. and the pH adjusted to 6-0. 2:3-Dimercaptopropanol (0.02 ml.) was added and the mixture kept at 37°. Samples for bioassay were removed at 41 and 90 hr. (b) 0 5 ml. was mixed with thioglycollic acid (0.02 ml., 15 mg.) and water (0-5 ml. Potass8ium borohydride. Peroxide-oxidized corticotropin (OC purified; 2-2 mg.) was dissolved in water (2 ml.) and KBH4 (20 mg.) added. The mixture was kept at 370, portions for bioassay being taken at 30, 60 and 120 min. These were acidified with acetic acid before dilution (Table 3 , Expt. 10).
Methionine. Corticotropin A1 (1 mg.) was dissolved in 01M-NaHCO1 and oxidized by the addition of 6 % H202 (3 x 0-01 ml.). The reaction was terminated by the addition of 2 N-acetic acid (1 ml.) and excess of H202 decomposed by shaking with platinum black. After separation from the platinum a portion was taken for direct bioassay. A volume (1 ml.) of the solution was treated with methionine (20 mg.) and maintained at 750 for 18 hr. A portion of the mixture was diluted for bioassay (Table 3, Expt. 11).
Treatment of corticotropin A1 with sodium p-chloromercuribenzoate Corticotropin A1 (0.22 mg.) was dissolved in water (1 ml.) and sodium p-chloromercuribenzoate (0 5 mg.) added. The mixture was shaken mechanically for 1 hr. and diluted to 4*4 ml. with 0-1 Nacetic acid. This solution was further diluted for bioassay (Table 4 , Expt. 12 a).
Oxidation-reduction of corticotropin A1 after treatment with sodium p-chloromercuribenzoate Corticotropin A1 (0.44 mg.) was dissolved in 0 02m-phosphate buffer, pH 7-5 (2-2 ml.) and 0-2 ml. was withdrawn for bioassay. The remainder of the solution was shaken with sodium p-chloromercuribenzoate (0-2 mg.) for 10 min. Oxidation was carried out as described earlier with 3 x 0-02 ml.
of 6 % (w/v) H202 for 45 min., the reaction being terminated by the addition of 0-1 N-acetic acid (2 ml.). Excess of H202 was decomposed with platinum black and, after centrifuging, the solution was passed through a 1 cm. x 0 7 cm. column of Dowex 2 x 8 acetate. The filtrate and column washings were diluted to 8 ml. with water. A portion of this solution was taken for direct bioassay, 2 ml. was treated with cysteine hydrochloride (40 mg.) for 18 hr. at 780 and finally diluted for bioassay. The results are given in Table 4 (Expt. 12b).
Raney-nickel desulphurization of corticotropin A1
Corticotropin A1 (2-2 mg.) was dissolved in a mixture of 0.1 N-acetic acid (0-4 ml.) and ethylene glycol monomethyl ether (purified by distillation (preparation 43/3) methionine, 2-8 %; Raneynickel-treated corticotropin A1 (43/3), less than 0-5%.
Oxidation and reduction of corticotropin Al treated with Raney nickel Raney-nickel-treated corticotropin A1 (0-09 mg.; methionine content less than 0-7 %) was dissolved in 0-01M-NaHCO3 (0-4 ml.). Oxidation was carried OXIDATION-REDUCTION OF CORTICOTROPIN out with 6 % (w/v) H202 (3 x 0-01 ml.) during 45 min.
The reaction was terminated by the addition of 2M-acetic acid (1.4 ml.) and excess ofH202 destroyed by shaking with platinum black. After removal of the platinum by centrifuging, a portion of the solution was removed for direct assay, and 1 ml. was reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. before bioassay. The results of this experiment, together with the bioassay of the desulphurized corticotropin A1, are given in Table 4 , Expt. 13a and b.
Effect of variou8 reagenrt on corticotropin A1 and peroxide-oxidized corticotropin Dimedone. Solutions of corticotropinA, (0 26 mg.) and oxidized corticotropin A1 (0.25 mg.) were prepared in 0 05M-acetate buffer, pH 4-6 (0-9 ml.).
A 1 % (w/v) ethanolic solution of dimedone (5:5-dimethylcyclohexane-1:3-dione; 0 1 ml.) was added to each solution, and the mixtures were kept at room temperature for 3 hr. Acetic acid (0-5N, 1 ml.) was then added to each. A volume (1 ml.) ofthe oxidized corticotropin *lution was reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. Portions of both solutiona-were diluted for bioassay (Table 4 , Expt. 14).
2:4-Dinitrophenylhydrazine. Oxycellulose-purified corticotropin (0.5 mg.) and a peroxide-oxidized corticotropin made from the same preparation (0 5 mg.) were each dissolved in a saturated solution of 2:4-dinitrophenylhydrazine in 99 % (v/v) acetic acid (0-1 ml.). The mixtures were kept at 700 for 10 min. and diluted with water to 1 ml. Excess of 2:4-dinitrophenylhydrazine was removed from each solution by passage through 3-5 cm. x 0-7 cm. columns of Amberlite IR-100 cation-exchange resin (H form) and the columns were washed with 0 1N-acetic acid (3 ml.). Eluates and washings from each column were combined. A volume (1 ml.) of the oxidized corticotropin solution was reduced with cysteine hydrochloride (20 mg.) at 78°for 18 hr. before bioassay (Table 4, Expt. 15).
Thio8emicarbazide. Oxycellulose-purified corticotropin (1 mg.) and a corresponding oxidized preparation (1 mg.) were dissolved in 0 1 N-acetic acid (1 ml.) and thiosemicarbazide (10 mg.) was added to each solution. The mixtures were kept for 6 hr. at room temperature, excess of thiosemicarbazide was removed by means of short columns of Amberlite IR-100 cation-exchange resin (H form; 0 5 g.) and the columns were washed with 0-05N-HCI (2 ml.). Both solutions were diluted with water to 6-3 ml. and the oxidized corticotropin solution was reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. before bioassay ( Alkali. Corticotropin A1 (0.33 mg.) and the corresponding peroxide-oxidized corticotropin A1 (0 3 mg.) were dissolved separately in water (1.4 ml. portions), and N-NaOH (0.1 ml.) was added to each solution. The ultraviolet absorption at 275 m,u was measured 30, 60 and 120 sec after the addition of alkali. Acetic acid (2N, 0 5 ml.) was added to both solutions after 2 min. in order to terminate the reaction. Portions of each solution were reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. and diluted for bioassay (Table 4, Expt. 17) . No change in the optical density at 275 m, was observed during the experimental period with either solution.
Acid.
Peroxide-oxidized corticotropin A1 (0.39 mg.) in 0-03N-HCI (2 ml.) was heated at 780 for 18 hr. After cooling, 1 ml. was diluted for direct bioassay and the remainder was reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. before dilution for bioassay (Table 4 , Expt. 21).
Cyanide. Peroxide-oxidized corticotropin A1
(0 53 mg.) in 0 1N-acetic acid (1.5 ml.) was treated with NaCN (1 mg.). After 30 min. CN ions were removed by exchange on Dowex 2 x 8 acetate (approx. 10 mg.). A portion of the solution was diluted for direct bioassay and a further 1 ml. portion reduced with cysteine hydrochloride (20 mg.) at 780 for 18 hr. A portion of the oxidized corticotropin A1 was reduced under identical conditions for comparison (Table 4 , Expt. 18).
p-Dimethylaminobenzaldehyde. Oxycellulose-purified corticotropin (2 mg.) and a corresponding peroxide-oxidized preparation (2 mg.) were each dissolved in 5N-HCI (0-05 ml.) and a 4 % (w/v) solution of p-dimethylaminobenzaldehyde in 5N-HOC (0-05 ml.) was added to each solution. The mixtures were kept at room temperature for 25 min. and water (1.4 ml.) was finally added to each. The absorption spectra of both solutions were measured at wavelengths from 530 to 640 m,u at 10 ml, intervals. No qualitative or quantitative differences were observed in the spectra (absorption maxima at 540 and 580 m,). Portions of each reaction mixture were diluted for bioassay. A portion of the oxidized corticotropin reaction mixture was reduced with cysteine hydrochloride (20 mg./ml.) at 780 for 18 hr. and diluted for bioassay. A control experiment was carried out with oxycellulose-purified corticotropin (2 mg.) in 5N-HCI (0.05 ml.). This solution was kept at room temperature for 25 min., neutralized and diluted for bioassay (Table 4 , Expt. 20).
lodination and oxidation of corticotropin A, Corticotropin A1 (1.1 mg.) in 0-05M-acetate buffer, pH 6-5 (0.7 ml.), was treated with 0-O1N-I2 solution (0.2 ml.), equivalent to 6 atoms of I/ tyrosine residue, calculated on a tyrosine content of 6-2 %. The mixture was kept at room temperature for 30 min. Measurement of the ultraviolet absorption at 312 mp indicated that 81 % of the Vol. 66 173 tyrosine was converted into 3:5-di-iodotyrosine. During the reaction period a small amount of precipitate formed. This was redissolved finally by the addition of 2N-acetic acid (0.5 ml.) to the mixture. Sodium thiosulphate (OO1N, 0-2 ml.) was then added to remove excess of I2 and anions in the mixture were exchanged for acetate by passage of the solution through a short column of Dowex 2 x 8 acetate. Eluate and column washings amounted to 2-9 ml.; 0-9 ml. of this solution was diluted for direct bioassay. Another portion (1 ml.) was adjusted to pH 7-0 and oxidized with 6 % (w/v) H202 (3 x 0-01 ml.). Excess of H202 was removed by shaking with platinum black. A portion of the separated supernatant liquid was diluted for bioassay, and a further portion reduced with cysteine hydrochloride (20 mg./ml.) at 750 for 18 hr. before bioassay (Table 4 , Expt. 19). Examination of the ultraviolet absorption of this solution at 312 m/ indicated that the 3:5-di-iodotyrosine content was unchanged.
DISCUSSION
The evidence presented in the Experimental section makes it clear that the adrenal ascorbic aciddepleting potency of corticotropin preparations can be destroyed by oxidation with hydrogen peroxide or ferricyanide and that the biological activity of such materials can be quantitatively restored by treatment with thiols. Up to the present time, no reducing agent other than a thiol compound has been found to be effective in this reduction. Ascorbic acid, potassium borohydride, sodium thiosulphate, hydrogen and platinum, zinc and hydrochloric acid and electrolytic reduction are equally ineffective in restoring the biological activity of peroxideoxidized corticotropin. Since the publication of our preliminary communication, the peroxide oxidation and thiol reduction of corticotropin have been confirmed by Dixon & Stack-Dunne (1955) , who have also demonstrated differences in the chromatographic behaviour of the untreated and oxidized forms (see also Dixon, 1955 Dixon, , 1956 (White, 1955) have shown to be essential for the biological activity of the hormone. The chemical nature of the oxidation-reduction centre in corticotropin is not readily explained by present knowledge of the structure of the hormone. Bell (1954) and Howard, Shepherd, Eigner, Davies & Bell (1955) determined the amino acid sequence of P-corticotropin, a highly purified and apparently homogeneous preparation obtained by countercurrent distribution of oxycellulose concentrates of pig corticotropin. The structure proposed by these workers is a single chain of thirty-nine amino acid residues. Part of this chain may be removed by the action of pepsin without reduction in biological activity. Biochem. J. (1953), 55, 5.] The amino acid composition of our preparation of corticotropin A1 given in Table 5 is consistent with the structure proposed by Bell (1954) and differs only in a somewhat higher proline content.
Countercurrent studies kindly carried out by Dr P. H. Bell, with a similar preparation, showed that it contained 67 % of P-corticotropin.
It may be concluded that the structure proposed for P-corticotropin by Howard et al. (1955) is also process. t Calculated from ultraviolet absorption (Beaven & In contrast to the action of hydrogen peroxide Holiday, 1952) . Only five of the amino acids present in the essential sequence could conceivably be involved in a reversible oxidation-reduction system: serine, tyrosine, methionine, histidine and tryptophan. The presence in the hormone molecule of a sulphydryl-disulphide system which has hitherto escaped detection is excluded by the failure of p-chloromercuribenzoate to prevent oxidation and subsequent reduction (Table 4 , Expt. 12), and by the fact that desulphurization with Raney nickel under very vigorous conditions also does not affect the oxidation-reduction process (Table 4 , Expt. 13). The latter finding also excludes methionine, as the analytical results show that the single residue of this amino acid in the hormone molecule can be completely desulphurized without change in the biological potency of corticotropin A1 and without impairing the ability to undergo reversible oxidation-reduction. It is interesting that the methionine contents of untreated and oxidized hormones given in Table 5 indicate that this amino acid is not converted into the sulphone or sulphoxide during the oxidation process.
Expts. 14, 15, 16 and 18 (Table 4) were designed to test the possibility that a carbonyl compound was formed on oxidation. A somewhat unlikely possibility was that the primary alcoholic group of the N-terminal serine residue might be oxidized to an aldehyde group either directly or through a hydroperoxide. If a carbonyl group were present in the oxidized form, reaction with carbonyl reagents such as dimedone, 2:4-dinitrophenylhydrazine or thiosemicarbazide should prevent subsequent reduction with restoration of biological activity. Expts. 14, 16 and 18 with dimedone, thiosemicarbazide and cyanide ions show that this blocking does not occur. Expt. 15 is less conclusive, owing to the inactivating effect of 2:4-dinitrophenylhydrazine on corticotropin itself, but does confirm the absence of the blocking effect. These experiments, together with the unchanged serine contents shown in Table 5 , eliminate the possibility of this amino acid being involved in the oxidation centre. It has never been demonstrated that histidine can take part in a reversible oxidation-reduction system, although have shown that it can be oxidized in intact proteins under relatively mild conditions. Photochemical oxidation at pH 8-3 in air, with methylene blue as oxygen carrier, resulted in a progressive irreversible inactivation, which was, however, not parallel to the decrease in the histidine content (Table 2, Expt. 7). The fall in histidine content to 22 % of the original value after photo-oxidation for 10 min., without any significant alteration in biological activity, indicates that this amino acid, like methionine, is probably not essential for hormonal activity. This fact, together with the unchanged histidine content of the oxidized hormone, makes it very improbable although not impossible that histidine is involved in the oxidation-reduction centre. It is possible that histidine, although not essential for biological activity, may be modified in the oxidized form, but the chemical basis for this is not clear, especially as the modified form must be chromatographically indistinguishable from the parent amino acid. The irreversible inactivation after further photo-oxidation is probably due to destruction of the aromatic amino acids .
The oxidation of tyrosine in intact proteins or peptides has been demonstrated many times, although there is very little evidence that a reversible process can occur. In the present case, the stability of the oxidized form to 0-1 N-NaOH (Table 4 , Expt. 17) makes it unlikely that the latter is a catechol derivative. This is confirmed by the apparent inability of the oxidized form to form an acidic boric acid complex. Hydroxylation by the method ofUdenfriend et al. (1954) , which specifically introduces hydroxyl groups into aromatic rings, results in irreversible inactivation of the hormone (Table 2, Expt. 6). This may, of course, be due to conversion of phenylalanine into tyrosine residues or hydroxylation of tryptophan in the hormone molecule.
Iodination of corticotropin A1 (Table 4 , Expt. 19) is more difficult to interpret. Iodination with 6 atoms of iodine/tyrosine residue at pH 6-5 gives a reaction product which is less active than the starting material. This can be oxidized with hydrogen peroxide to an almost inactive product, which can in turn be reduced to give a biologically active material which is intermediate in activity between the original and the iodinated hormone. lodination thus does not appear to eliminate the oxidation-reduction centre, although it does lead to some irreversible inactivation.
The evidence of these experiments, together with the unaltered ultraviolet absorption spectra of the oxidized form under both acid and alkaline conditions (Fig. 2) and the unchanged tyrosine content (Table 5) , make it very unlikely that tyrosine is involved in the oxidation-reduction centre of corticotropin.
The evidence for tryptophan is less conclusive. It is clear from the identity of the ultravioletabsorption spectra of untreated and oxidized corticotropins that no extensive changes in the tryptophan molecule can occur. The tryptophan contents of the two preparations, estimated from the spectra by the method of Beaven & Holiday (1952) , are very similar, although that of the oxidized preparation is somewhat lower.
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Condensation of both untreated and oxidized preparations with p-dimethylaminobenzaldehyde in the presence of strong hydrochloric acid (Table 4 , Expt. 20) leads to irreversible inactivation in both cases, indicating that the 2 position of the tryptophan residue is probably essential for biological activity, although the possibility of side reactions cannot be excluded. The identical absorption spectra of the coloured condensation products suggests that the 2 positions of the tryptophan residues are probably in similar states in both preparations and excludes a residue such as oxindolylalanine in the oxidized form. This conclusion is also supported by the ultraviolet-absorption spectra in alkaline solution (Cornforth, Dalgliesh & Neuberger, 1951) .
The oxidation products of tryptophan have attracted some attention in recent years because of their importance in the first stages ofthe metabolism of this amino acid. A number of possible hydroxylated or peroxide derivatives have been suggested [reviewed by Ek, Kissman, Patrick & Witkop (1952) and by Dalgliesh (1955) alanine none of these has been isolated or synthesized, so that their properties are unknown. The relatively high stability of oxidized corticotropin under acid (Table 4 , Expt. 21) and alkaline conditions (Table 4 , Expt. 17) makes its formulation as a hydroperoxide unlikely. Houff, Hinsvark, Weller, Wittiver & Sell (1954) have suggested that N-hydroxyindole derivatives are formed when certain indole compounds are oxidized with ferric chloride and perchloric acid. The indoles examined included several substituted carboxylic acids, but did not include tryptophan.
Attempts to prepare similar Nl-hydroxy derivatives from tryptophan or acetyltryptophan in this laboratory have been unsuccessful. Houff et al. (1954) postulate a dimer as an intermediate in the formation of the N-hydroxyindoles, and it is possible that the formation of this compound is difficult with tryptophan or its peptides.
The experiments reported here, together with amino acid analyses presented in Table 5 , make it improbable that any of these amino acids are concerned in the oxidation-reduction process. A possible exception is provided by histidine and by tryptophan, where the evidence is less conclusive and where a variety of oxidation products are theoretically possible.
Two alternatives remain: either the substance isolated as ,-corticotropin is not in fact the biologically active hormone or the fl-corticotropin molecule contains some hitherto unidentified group which determines the oxidation-reduction behaviour. The former alternative appears extremely unlikely in view of the impressive evidence of homogeneity presented by Bell (1954) . SUMMARY 1. The conditions for the oxidation of corticotropin to a biologically inactive product assayed by the adrenal ascorbic acid-depletion method, and for the reduction of this material with complete restoration of activity, have been investigated.
2. The nature of the groupings concerned in the oxidation-reduction process have been examined by studying the effect of various chemical treatments on this process.
3. Amino acid analyses ofuntreated and oxidized corticotropin A1 are presented.
4. The chemical nature of the oxidation-reduction centi-e is discussed. It is concluded that, with the possible exception oftryptophan, the oxidationreduction behaviour of the hormone cannot be accounted for by the amino acid residues known to be present in the corticotropin molecule.
The authors are indebted to Miss G. Atfield, who carried out the amino acid analyses by ion-exchange chromatography. 
